Transplacental immune modulation with a bacterial-derived agent protects against allergic airway inflammation (original) (raw)

A study investigates the role of transplacental immune modulation through the bacterial-derived agent OM-85 in preventing allergic airway inflammation in offspring. Evidence from mouse models shows that maternal treatment with OM-85 enhances the immune response in fetuses, improving their protection against respiratory allergies post-birth. This research supports the potential of maternal microbial exposures as a therapeutic approach for asthma prevention by shaping the fetal immune system during pregnancy.